SOMATOSTATINE UCB Infusion
Somatostain (as acetate hydrate)
3mg
UCB PHARMACEUTICALS
| Pack size | 1 Vial (Dry) + 1 Solvent Ampoule (1ml) |
|---|---|
| Dispensing mode | POM |
| Source | BELGIUM |
| Agent | Modern Pharmaceutical Co. |
| Retail Price | 969.00 AED |
Available as:
Indications
SOMATOSTATINE UCB Infusion is used for:
For treatment of dwarfism, acromegaly and prevention of HIV-induced weight loss
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Somatostain (as acetate hydrate) :
Mechanism of Action
hGH binds to the human growth hormone receptor (GHR). Upon binding, hGH causes dimerization of GHR, activation of the GHR-associated JAK2 tyrosine kinase, and tyrosyl phosphorylation of both JAK2 and GHR. These events recruit and/or activate a variety of signaling molecules, including MAP kinases, insulin receptor substrates, phosphatidylinositol 3' phosphate kinase, diacylglycerol, protein kinase C, intracellular calcium, and Stat transcription factors. These signaling molecules contribute to the GH-induced changes in enzymatic activity, transport function, and gene expression that ultimately culminate in changes in growth and metabolism.
Note
SOMATOSTATINE UCB 3mg Infusion manufactured by UCB PHARMACEUTICALS. Its generic name is Somatostain (as acetate hydrate). SOMATOSTATINE UCB is availble in United Arab Emirates.
Farmaco UAE drug index information on SOMATOSTATINE UCB Infusion is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.